Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Delic Holdings Corp DELCF

Delic Holdings Corp. is a Canada-based company. The Company owns and operates a self-sustaining umbrella of businesses in the psychedelic ecosystem consisting of media, science and health. The Company’s subsidiaries include Delic Corp., Delic Labs Inc. (Delic Labs), Ketamine Infusion Centers, LLC (KIC), and Ketamine Wellness Centers, LLC (KWC). Delic Corp. is an international media ecosystem... see more

GREY:DELCF - Post Discussion

View:
Post by yopmemama021 on Aug 10, 2021 4:39pm

DELC.CN

$DELC.CN $DELCF @ $0.29 , tiny mc 

 

 Professor Glenn Sammis, Scientific Advisor of Delic Labs has been granted a full professorship at the University of British Columbia as a member of the Chemistry Department! 

 

He has further taken a 12 month sabbatical from UBC to devote the next year  to working closely with Dr. Markus Roggen in developing intellectual property  for Delic Labs' cannabis and psilocybin research. 

 

He is super stoked to be conducting intensive research alongside Dr. Roggen while building their  valuable IP. 

 

“Our unique and early testing of lesser-known compounds and practices will give us a first-mover advantage in the medical psychedelic space.” - Professor Sammis. 

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities